Goodbody upgraded shares of Bunzl (LON:BNZL – Free Report) to a buy rating in a research note released on Tuesday morning, Marketbeat reports. Goodbody currently has GBX 3,200 ($40.41) target price on the stock.
BNZL has been the subject of a number of other reports. Royal Bank of Canada downgraded Bunzl to an underperform rating and decreased their price target for the company from GBX 2,850 ($35.99) to GBX 2,550 ($32.21) in a research note on Wednesday, July 12th. Shore Capital restated a buy rating on shares of Bunzl in a research note on Tuesday, August 29th. Finally, Jefferies Financial Group reiterated a hold rating and set a GBX 2,950 ($37.26) target price on shares of Bunzl in a research note on Monday, May 22nd. Two analysts have rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Bunzl presently has a consensus rating of Hold and a consensus target price of GBX 2,989.17 ($37.75).
Get Our Latest Research Report on BNZL
Bunzl Stock Down 2.1 %
Bunzl Cuts Dividend
The firm also recently announced a dividend, which will be paid on Wednesday, January 3rd. Stockholders of record on Thursday, November 16th will be paid a dividend of GBX 18.20 ($0.23) per share. The ex-dividend date of this dividend is Thursday, November 16th. This represents a dividend yield of 0.64%. Bunzl’s dividend payout ratio is currently 4,468.09%.
About Bunzl
Bunzl plc operates as a distribution and services company in the North America, Continental Europe, the United Kingdom, Ireland, and internationally. The company offers food packaging, films, labels, cleaning and hygiene supplies, and personal protection equipment to grocery stores, supermarkets, and convenience stores.
Recommended Stories
- Five stocks we like better than Bunzl
- How to Invest in Semiconductors
- 5 Ways to Play Retail that will Profit in 2023
- What Are MATANA Stocks?
- This Is Why It’s Not Too Late For You To Buy Meta Stock
- How Technical Indicators Can Help You Find Oversold Stocks
- Why Analysts Say GE’s Healthcare Spinoff Has $20 Upside
Receive News & Ratings for Bunzl Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bunzl and related companies with MarketBeat.com's FREE daily email newsletter.